Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition
Journal of Korean Medical Science
;
: 468-484, 2014.
Article
Dans Anglais
| WPRIM
| ID: wpr-216491
ABSTRACT
This paper aims to introduce, summarize, and emphasize the importance of the 'Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition'. The guideline broadly covers most aspects of the pharmacological treatment of patients in Korea diagnosed with moderate to severe major depression according to the DSM-IV TR. The guideline establishment process involved determining and answering a number of key questions, searching and selecting publications, evaluating recommendations, preparing guideline drafts, undergoing external expert reviews, and obtaining approval. A guideline adaptation process was conducted for the revised edition. The guideline strongly recommends pharmacological treatment considered appropriate to the current clinical situation in Korea, and should be considered helpful when selecting the appropriate pharmacological treatment of patients diagnosed with major depressive disorder. Therefore, the wide distribution of this guideline is recommended.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Troubles psychotiques
/
Neuroleptiques
/
Indice de gravité de la maladie
/
Effet placebo
/
Bases de données factuelles
/
Inhibiteurs de la capture des neurotransmetteurs
/
Dépression
/
Tolérance aux médicaments
/
Pratique factuelle
/
République de Corée
Type d'étude:
Guide de pratique
Limites du sujet:
Humains
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Journal of Korean Medical Science
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS